A Severe Case of Congenital Thrombotic Thrombocytopenia Purpura Resulting From Compound Heterozygosity Involving a Novel ADAMTS13 Pathogenic Variant

被引:5
作者
Conboy, Erin [1 ]
Partain, Paige I. [2 ]
Warad, Deepti [4 ]
Kluge, Michelle L. [3 ]
Arndt, Carola [5 ]
Chen, Dong [3 ]
Rodriguez, Vilmarie [5 ]
机构
[1] Mayo Clin, Dept Clin Genom, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Pediat & Adolescent Med, 200 First St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Lab Med & Pathol, 200 First St SW, Rochester, MN 55905 USA
[4] Mayo Clin, Div Hematopathol, Special Coagulat Lab, 200 First St SW, Rochester, MN 55905 USA
[5] Mayo Clin, Div Pediat Hematol & Oncol, Special Coagulat Lab, 200 First St SW, Rochester, MN 55905 USA
关键词
thrombotic thrombocytopenic purpura; TTP; congenital; mutation; pathogenic variant; ADAMTS13; Upshaw-Schulman syndrome; VON-WILLEBRAND-FACTOR; FACTOR CLEAVING PROTEASE; MUTATIONS;
D O I
10.1097/MPH.0000000000000895
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report a 9-year-old Chinese girl with congenital thrombotic thrombocytopenic purpura found to be a compound heterozygote for 2 pathogenic variants in the ADAMTS13 gene, including a novel variation. The girl suffered from recurrent, life-threatening episodes of thrombocytopenia and hemolysis, and laboratory testing showed ADAMST13 enzyme activity of < 5%. Sequencing of the ADAMTS13 gene revealed a previously reported missense variant, c.1787C > T (p.Ala596Val), and a novel duplication defined as c.1007_1025dup19 (p.Asp343Leufs*53); the duplication is predicted to result in a premature stop codon and protein truncation. We propose that this novel variant is partly responsible for the patient's early-onset and severe phenotype.
引用
收藏
页码:60 / 62
页数:3
相关论文
共 15 条
[1]   N-Acetylcysteine for Relapsing Thrombotic Thrombocytopenic Purpura: More Evidence of a Promising Drug [J].
Cabanillas, Gerardo ;
Popescu-Martinez, Andrea .
AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (05) :E1277-E1279
[2]   A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom [J].
Camilleri, R. S. ;
Scully, M. ;
Thomas, M. ;
Mackie, I. J. ;
Liesner, R. ;
Chen, W. J. ;
Manns, K. ;
Machin, S. J. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) :1792-1801
[3]   N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice [J].
Chen, Junmei ;
Reheman, Adili ;
Gushiken, Francisca C. ;
Nolasco, Leticia ;
Fu, Xiaoyun ;
Moake, Joel L. ;
Ni, Heyu ;
Lopez, Jose A. .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (02) :593-603
[4]   In-vitro and in-vivo consequences of mutations in the von Willebrand factor cleaving protease ADAMTSI3 in thrombotic thrombocytopenic purpura [J].
Donadelli, Roberta ;
Banterla, Federica ;
Galbusera, Miriam ;
Capoferri, Cristina ;
Bucchioni, Sara ;
Gastoldi, Sara ;
Nosari, Silvia ;
Monteferrante, Giuseppe ;
Ruggeri, Zaverio M. ;
Bresin, Elena ;
Scheiflinger, Friedrich ;
Rossi, Edoardo ;
Martinez, Constantino ;
Coppo, Rosanna ;
Remuzzi, Giuseppe ;
Noris, Marina .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (04) :454-464
[5]   Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan [J].
Fujimura, Y. ;
Matsumoto, M. ;
Isonishi, A. ;
Yagi, H. ;
Kokame, K. ;
Soejima, K. ;
Murata, M. ;
Miyata, T. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 :283-301
[6]  
George JN, 2014, NEW ENGL J MED, V371, P1847, DOI [10.1056/NEJMra1312353, 10.1056/NEJMc1410951]
[7]   Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome) [J].
Hommais, Antoine ;
Rayes, Julie ;
Houllier, Anne ;
Obert, Bernadette ;
Legendre, Paulette ;
Veyradier, Agnes ;
Girma, Jean-Pierre ;
Ribba, Anne-Sophie .
THROMBOSIS AND HAEMOSTASIS, 2007, 98 (03) :593-599
[8]   Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura [J].
Levy, GG ;
Nichols, WC ;
Lian, EC ;
Foroud, T ;
McClintick, JN ;
McGee, BM ;
Yang, AY ;
Siemieniak, DR ;
Stark, KR ;
Gruppo, R ;
Sarode, R ;
Shurin, SB ;
Chandrasekaran, V ;
Stabler, SP ;
Sabio, H ;
Bouhassira, EE ;
Upshaw, JD ;
Ginsburg, D ;
Tsai, HM .
NATURE, 2001, 413 (6855) :488-494
[9]   Treatment of refractory thrombotic thrombocytopenic purpura with N-acetylcysteine: a case report [J].
Li, Gloria W. ;
Rambally, Siayareh ;
Kamboj, Jasmine ;
Reilly, Sean ;
Moake, Joel L. ;
Udden, Mark M. ;
Mims, Martha P. .
TRANSFUSION, 2014, 54 (05) :1221-1224
[10]   Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS) [J].
Licht, C ;
Stapenhorst, L ;
Simon, T ;
Budde, U ;
Schneppenheim, R ;
Hoppe, B .
KIDNEY INTERNATIONAL, 2004, 66 (03) :955-958